Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Top Cited Papers
- 29 June 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (3) , 425-431
- https://doi.org/10.1016/j.jacc.2005.04.038
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registryEuropean Heart Journal, 2004
- What Causes Sudden Death in Heart Failure?Circulation Research, 2004
- Mineralocorticoid Receptor Antagonism Prevents the Electrical Remodeling That Precedes Cellular Hypertrophy After Myocardial InfarctionCirculation, 2004
- Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary SyndromesCirculation, 2004
- Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial InfarctionCirculation, 2003
- Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trialsAmerican Heart Journal, 2003
- Heterogeneity in the Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Heart FailureCirculation, 2002
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.Hypertension, 1994
- Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot studyThe American Journal of Cardiology, 1989